Literature DB >> 31678769

Overestimated treatment effects in randomised phase II trials: What's up doctor?

Stefan Michiels1, James Wason2.   

Abstract

Year:  2019        PMID： 31678769     DOI： 10.1016/j.ejca.2019.09.023

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Efficacy and Tolerability of Two Novel "Standard of Care" Treatments-Intranasal Esketamine Versus Intravenous Ketamine-for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study.

Authors:  Gilmar Gutierrez; Joshua Rosenblat; Emily Hawken; Jennifer Swainson; Gustavo Vazquez
Journal:  JMIR Res Protoc       Date:  2022-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.